Literature DB >> 32103336

Identification of TSC1 or TSC2 mutation limited to the tumor in three cases of solitary subependymal giant cell astrocytoma using next-generation sequencing technology.

Martine Fohlen1, Ines Harzallah2, Marc Polivka3, Fabienne Giuliano4, Linda Pons5, Nathalie Streichenberger6,7, Georg Dorfmüller8, Renaud Touraine2.   

Abstract

PURPOSE: Subependymal giant-cell astrocytomas (SEGAs) are low grade intraventricular tumors typically found in patients with tuberous sclerosis complex (TSC). The occurrence of SEGA in non TSC patients is very rare and from a genetic point of view these so-called solitary SEGA are thought to result either from somatic mutations in one of the TSC genes (TSC1 or TSC2) limited to the tumor, or be part of a "forme fruste" of TSC with somatic mosaicism. We report on three new cases of solitary SEGA with germline and somatic mutation analysis.
METHODS: We retrospectively analyzed TSC genes in three patients with a solitary SEGA using next-generation sequencing technique.
RESULTS: In the three patients, a somatic mutation of TSC1 or TSC2 was found only in the tumor cells: one patient had a TSC1 heterozygote mutation, involving the natural acceptor splicing site of intron 15 (c.1998-1G > A (p.?). Two patients had a TSC2 mutation located in the canonical splicing donor site of intron 5 (c.599 + 1G > A) in 70% of the alleles in one patient and in exon 9: c.949_955dup7 (p.V319DfxX21) in 25 of the alleles in the second patient. No other TSC mutations were found in patient's blood or tumor and those identified mutations were absent in blood DNA from parents and siblings.
CONCLUSION: We therefore conclude that solitary SEGA can occur with a TSC1 or TSC2 mutation limited to the tumor in patients without TSC.

Entities:  

Keywords:  Next-generation sequencing; Solitary subependymal giant cell astrocytoma; TSC1; TSC2; Tuberous sclerosis complex

Mesh:

Substances:

Year:  2020        PMID: 32103336     DOI: 10.1007/s00381-020-04551-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  27 in total

1.  Solitary subependymal giant cell astrocytoma: case report.

Authors:  N Kashiwagi; W Yoshihara; N Shimada; H Tanaka; N Fujita; N Hirabuki; Y Watanabe; H Nakamura
Journal:  Eur J Radiol       Date:  2000-01       Impact factor: 3.528

2.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

3.  Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report.

Authors:  Thomas L Beaumont; Jakub Godzik; Sonika Dahiya; Matthew D Smyth
Journal:  J Neurosurg Pediatr       Date:  2015-05-15       Impact factor: 2.375

4.  Germ-line mosaicism in tuberous sclerosis: how common?

Authors:  V M Rose; K S Au; G Pollom; E S Roach; H R Prashner; H Northrup
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

5.  Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis.

Authors:  R Nabbout; M Santos; Y Rolland; O Delalande; O Dulac; C Chiron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

6.  High rate of mosaicism in tuberous sclerosis complex.

Authors:  S Verhoef; L Bakker; A M Tempelaars; A L Hesseling-Janssen; T Mazurczak; S Jozwiak; A Fois; G Bartalini; B A Zonnenberg; A J van Essen; D Lindhout; D J Halley; A M van den Ouweland
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 7.  Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.

Authors:  E S Roach; M R Gomez; H Northrup
Journal:  J Child Neurol       Date:  1998-12       Impact factor: 1.987

8.  Subependymal giant cell astrocytoma with positive tuberin expression--case report.

Authors:  Sadaharu Tabuchi; Haruo Takigawa; Akira Oka; Masashi Mizuguchi; Yasushi Horie; Takashi Watanabe
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-12       Impact factor: 1.742

9.  Surgical treatment of intraventricular tumors associated with tuberous sclerosis.

Authors:  M Roszkowski; K Drabik; S Barszcz; S Jozwiak
Journal:  Childs Nerv Syst       Date:  1995-06       Impact factor: 1.475

10.  TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.

Authors:  John C Kingswood; Guillaume B d'Augères; Elena Belousova; José C Ferreira; Tom Carter; Ramon Castellana; Vincent Cottin; Paolo Curatolo; Maria Dahlin; Petrus J de Vries; Martha Feucht; Carla Fladrowski; Gabriella Gislimberti; Christoph Hertzberg; Sergiusz Jozwiak; John A Lawson; Alfons Macaya; Rima Nabbout; Finbar O'Callaghan; Mirjana P Benedik; Jiong Qin; Ruben Marques; Valentin Sander; Matthias Sauter; Yukitoshi Takahashi; Renaud Touraine; Sotiris Youroukos; Bernard Zonnenberg; Anna C Jansen
Journal:  Orphanet J Rare Dis       Date:  2017-01-05       Impact factor: 4.123

View more
  1 in total

Review 1.  A second hit somatic (p.R905W) and a novel germline intron-mutation of TSC2 gene is found in intestinal lymphangioleiomyomatosis: a case report with literature review.

Authors:  Bogyeong Han; Juhwan Lee; Yoon Jin Kwak; Hyun-Young Kim; Kwang Hoon Lee; Yumi Shim; Hyunju Lee; Sung-Hye Park
Journal:  Diagn Pathol       Date:  2021-08-31       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.